("Agronomics" or the "Company")
Agronomics (ANIC:LSE), the leading listed company focused on the field of cellular agriculture, is pleased to announce that Chinese cultivated meat company
● CellX and Tofflon will build
● The facility will allow CellX to scale up its suspension cell lines in serum-free media at thousand-litre scale
● The facility will be
Agronomics has invested a total of
The full announcement is set out below without any material changes.
The two companies hope to leverage CellX's technical expertise in cultivated meat and Tofflon's extensive biological equipment & production capability to accelerate the scaling up of CellX's cultivated meat products.
During the signing event, CellX and Tofflon shared the rendering of
The facility will host multiple thousand-litre bioreactors and will provide an interactive space for consumers to taste CellX's demo products. It will be
"CellX is the leading cultivated meat company in
"As part of our strategic partnership, the construction of a pilot facility is the cornerstone of CellX's journey to scale up cultivated meat production in
As a branch of cellular agriculture, cultivated meat produces animal meat directly from animal cells in large-scale bioreactors. This new production method is more efficient and sustainable than traditional factory farming methods.
In the future, CellX and Tofflon will work together to bring cultivated meat to consumers in
About Tofflon
Tofflon (Stock Code: SZ 300171) was founded in 1993 and listed on the
Tofflon has established collaborations with pharmaceutical and biopharma companies around the world and accumulated a wealth of pharmaceutical and biopharma engineering technology, core equipment manufacturing technology, and engineering design cases. By focusing on cutting-edge technologies in the pharmaceutical industry, exploring innovative drug manufacturing models, and building an advanced drug manufacturing platform, Tofflon has grown from a "System Solution Supplier" to a "Smart Pharma Factory Builder".
About CellX
CellX is a cellular agriculture company based in
CellX is collaborating with top universities and leading companies around the world to advance the commercialization of cultivated meat. The company is also accelerating market launch and cultivated meat approval in the APAC region.
More information at www.cellx.cn
About Agronomics
Agronomics is a leading listed alternative proteins company with a focus on cellular agriculture and cultivated meat. The Company has established a portfolio of over 20 companies in this rapidly advancing sector. It seeks to secure minority stakes in companies owning technologies with defensible intellectual property that offer new ways of producing food and materials with a focus on products historically derived from animals. These technologies are driving a major disruption in agriculture, offering solutions to improve sustainability, as well as addressing human health, animal welfare and environmental damage. This disruption will decouple supply chains from the environment and animals and be fundamental to feeding the world's expanding population. A full list of Agronomics' portfolio companies is available at https://agronomics.im/.
About Cellular Agriculture
Cellular Agriculture is the production of agriculture products directly from cells, as opposed to raising an animal for slaughter or growing crops. This encompasses cell culture to produce cultivated meat and materials, and fermentation processes that harness a combination of molecular biology, synthetic biology, tissue engineering and biotechnology to massively simplify production methods in a sustainable manner.
Over the coming decades, the source of the world's food supply traditionally derived from conventional agriculture is going to change dramatically. We have already witnessed the first wave of this shift with the consumer adoption of plant-based alternative proteins but today, we are on the cusp of an even bigger wave of change. This is being facilitated by advances in cellular agriculture. This change is necessary, given scientists' claims that if we maintain existing animal protein consumption patterns, then we will not meet the Paris Agreement's goal of limiting warming to 1.5℃.
AT Kearney, a global consultancy firm, projects that cultivated meat's market share will reach 35% by 2040. This combined with the
For further information please contact:
Agronomics Limited |
Beaumont |
|
Cenkos |
Limited |
TB Cardew |
The Company |
Nomad |
Joint Broker |
Joint Broker |
Joint Broker |
Public Relations |
|
|
|
|
|
|
+44 (0) 1624 639396 |
+44 (0) 207 628 3396 |
+44 (0) 207 523 8000 |
+44 (0) 207 397 8900 |
+44 (0) 207 469 0936 |
+44 (0) 20 7930 0777 +44 (0) 7738 724 630 |